Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline ...

Eletrobras' recent earnings show progress in revenue generation and deleveraging. Read why I reiterate my bullishness on EBR ...

Eletrobrás' agreement reduces governance risks, limiting state influence and avoiding mandatory investments in Angra 3. Read ...

Delivering successful investment ideas depends on managing complexity and consistently outthinking the market. Discover the Bloomberg tools designed to help analysts save time and react quickly during ...

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...

FIVE stock up on Q4 earnings beat amid exciting earnings season. JPMorgan rates Underweight, Goldman Sachs rates Buy.

Next week is jam-packed with economic data. There are also a handful of notable earnings reports due out from Chewy (CHWY), ...

It’s not really fair or logical, but it’s the price you pay to play in March. It’s the power and the pain of Madness.

Cuts to the federal workforce have multifamily pros wondering about potential effects on one of the country's hottest markets ...

Fiercely competitive and innovative, the country is bound to succeed. But four issues must be borne in mind Much ink has been ...

“The Place of Shells” by Mai Ishizawa, a strange and slim novel of erudition, captures the emotional haze in the aftermath of disaster. Ishizawa’s debut novel, which won one of the three ...

Regardless of the direction in which the final in Dubai goes today, the ICC Champions Trophy has given the beleaguered 50-over format a leg up. Seemingly trapped in an identity crisis, neither ...